Minimization of Surgical Site Infections in Patients With Delayed Sternal Closure After Pediatric Cardiac Surgery

Mouhammad Yabrodi1, Jeremy L Hermann2, John W Brown2

  • 11 Division of Critical Care, Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, Indianapolis, IN, USA.

Insights

Delayed sternal closure (DSC) in pediatric cardiac surgery can lead to infections. This study found that closing the skin over the open sternum reduced infectious complications to 9.1%, a lower rate than previously reported.

Area of Science:

  • Pediatric Cardiac Surgery
  • Thoracic Surgery
  • Infectious Disease

Background:

  • Delayed sternal closure (DSC) is common after pediatric cardiac surgery.
  • Infectious complications affect 18.7% of patients undergoing DSC.
  • This study investigates institutional practices to minimize infection risk during DSC.

Purpose of the Study:

  • To describe institutional experience with DSC.
  • To test the hypothesis that specific DSC practices reduce infectious complications.
  • To compare infectious complication rates with existing literature.

Main Methods:

  • Retrospective review of 165 pediatric patients (<365 days) undergoing DSC (2012-2016).
  • Infectious complications defined by Society of Thoracic Surgeons Congenital Heart Surgery Database criteria.
  • Comparison of patient characteristics with and without infectious complications using statistical tests.

Main Results:

  • 165 patients underwent DSC; 82% had skin closure over the open sternum.
  • Median duration of open sternum was 3 days.
  • Infectious complications occurred in 9.1% of patients (sepsis, pneumonia, wound infection), with no mediastinitis.

Conclusions:

  • Institutional DSC practices resulted in fewer infectious complications than previously reported.
  • Closing skin over the open sternum may reduce surgical site infections.
  • These practices could help other centers minimize DSC-related infectious complications.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.2K